Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

CNS-directed AAV gene therapy shows milder immune responses compared to systemic ... via IP delivery exhibited minimal changes in B-cell responses, regardless of baseline anti-AAV titers or ...

Expect in-depth discussions covering revolutionary technologies used for precision genome editing, advancements and innovations in immune effector cell therapies, and the growing role or AI in gene ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

"We discovered that disrupting the Axsl1 gene in T cells resulted in a better response to immune checkpoint blockade ...

"We discovered that disrupting the Axsl1 gene in T cells resulted in a better response to immune checkpoint blockade ... Transplantation and Cellular Therapy. T cells that encounter too many ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

T cells serve an important role in coordinating immune responses and removing pathogen-infected ... India's first home-grown ...

Only lentiviruses are able to infect nonproliferating cells because their re-transcribed ... of more than 30 children with restored immune system. Gene therapy for SCID-X1: 18 of 20 children ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

A world-first clinical trial to test a gene therapy for type 1 diabetes ... the condition occurs when the body's immune system attacks its own islet cells in the pancreas, which are responsible for ...

Genprex (GNPX) announced that its research collaborators at Meharry Medical College will present a poster detailing positive preclinical data from a study of the Company’s lead drug candidate, Reqorsa ...